CDSCO Ends Emergency-Use Authorization of Baricitinib for COVID-19 Treatment Susmita Roy25 Oct 2025 3:35 PM ISTNew Delhi: In a recent regulatory update, the Central Drugs Standard Control Organisation (CDSCO) has formally approved the withdrawal of COVID-19...
CDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of Standard Quality Susmita Roy25 Oct 2025 1:53 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has identified 112 batches of medicines and medical products as "Not of Standard...
Torrent Pharma Receives SEC Approval to Market Alogliptin-Metformin FDC, Asked to Conduct Phase IV Trial Susmita Roy23 Oct 2025 1:44 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted approval to...
CDSCO Panel Seeks More Toxicity Data from Macleods on Semaglutide Injection Pre-Filled Pens Susmita Roy23 Oct 2025 1:28 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has opined that Macleods...
Unique Pharma Asked To Revise BE Study Protocol for Cilnidipine-Metoprolol FDC Parthika Patel22 Oct 2025 8:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Unique Pharmaceutical...
Beta Drugs' Methotrexate Oral Solution Gets SEC Manufacturing, Marketing Nod Parthika Patel22 Oct 2025 8:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to...
Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths Susmita Roy21 Oct 2025 1:00 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Biocon...
CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Susmita Roy21 Oct 2025 12:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted permission to...
CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Susmita Roy20 Oct 2025 5:44 PM ISTNew Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection Susmita Roy20 Oct 2025 5:35 PM ISTNew Delhi: In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee (SEC) functional...
MSN Labs Gets SEC Nod for Roflumilast as Starting Dose in COPD Therapy Parthika Patel19 Oct 2025 12:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended the grant of permission to...
CDSCO Panel Flags Small Sample Size, Limited Scope, Asks Zydus to Rework Phase IV Letermovir Study Parthika Patel18 Oct 2025 6:55 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Zydus Lifesciences Ltd to...
